Breast cancer is a known heterogeneous disease. Current clinically utilized histopathologic biomarkers may undersample tumor heterogeneity, resulting in higher rates of misdiagnosis for breast cancer. MRI can provide a whole-tumor sampling of disease burden and is widely utilized in clinical care. Texture analysis can provide a localized description of breast cancer, with particular emphasis on quantifying breast lesion heterogeneity. The object of this review is to provide an overview of texture analysis applications towards breast cancer diagnosis, prognosis, and treatment response evaluation and review the role of image-based texture features as noninvasive prognostic and predictive biomarkers. Level of Evidence: 5 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2019;49:927-938. View this article online at wileyonlinelibrary.com.
Applications in Breast Computer-Aided DiagnosisComputer-aided diagnosis (CAD) of breast tissue was one of the earliest applications of texture analysis in the breast. 41 Gibbs and Turnbull 42 were one of the first to apply texture analysis toward classifying breast lesions as benign or malignant. The authors reported using 2D DCE-MR images from a cohort of 79 women, of which 45 were diagnosed with breast cancer. An ROI was selected to encompass the entire lesion, within which gray-level intensity values were discretized to 32 levels. Within each lesion ROI, a co-occurrence matrix was determined for adjoining pixels in 0 , 45 , 90 , and 135 directions. The co-occurrence matrices of each direction were averaged and 14 GLCM texture features were extracted. Texture features of variance, sum entropy, and 928